High Potent Medicines Conference
18
Apr
-
19
Apr
2024
When
Boston

USA
Where

Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.

In today's market scenario, numerous companies are opting to outsource the manufacturing of their highly potent compounds for various reasons, particularly for marketing purposes. The high potent drug market is experiencing rapid growth due to several factors, including the shift of pharmaceutical manufacturers towards precision medicines like HPAPI (Highly Potent Active Pharmaceutical Ingredients), the rising demand for oncology drugs and antibody-drug conjugates, and the advancements in HPAPI manufacturing technologies.

At this conference, we are thrilled to present some of the brightest minds in the medical and pharmaceutical industry. They will share their insights and expertise, providing valuable solutions to the challenges faced in advanced high potent medicines. This is a unique opportunity to interact with industry leaders, gain knowledge from their experiences, and expand your professional network.

Over the course of two days, you will have access to 10+ hours of dedicated networking sessions, allowing you to connect with like-minded professionals, potential partners, and key decision-makers. By attending this event, you will not only stay updated on the latest developments in high potent medicines but also have the chance to meet your potential targets and create targeted revenue.

Don't miss out on this exceptional opportunity to be a part of the High Potent Medicines Conference. Register now to secure your spot and join us in Boston for a transformative experience that will shape the future of the high potent medicines industry.

Similar Events

You May Like

event-img
(0)
06-07 March 2024
The 11th Edition of Mexico Health Summit
event-img
event-img
(0)
15-17 April 2024
Festival of Biologics USA 2024
event-img

Event

MarketsandMarkets

0/5
(0)

In the decade of the 2020s, the B2B world will see $25 trillion worth of disruptive revenue shifts. Organizations globally are navigating both the opportunities and risks that are consequent.

18 - 19 Apr 2024
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

President and CEO
Sr. Manager, Cleaning Validation
Associate Director, Pharmacometrics
Associate Director, Head of Drug Product
Project Lead

Sponsors and Exhibitors
Brand, Media and Promotional Partners

FPS Food and Pharma Systems srl

FPS is an Italian company specialized in the design and manufacture of containment & isolation systems and micronization solutions for the handling and production of active and sterile pharmaceutical ingredients; it is mainly addressed to pharmaceuti

BSP Pharmaceuticals S.p.A.

BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006.

CTS Europe Limited

Containment Technology Services specialise in the design, construction and commissioning of mobile and bench mounted containment systems to the Pharmaceutical industry. Our enclosure systems are designed to provide safe handling environments for the

Organizer

Get emails from us

 
Thank you
Oops! Something went wrong